1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PYGO1 CTRPv2 pan-cancer AAC -0.14 0.0007
mRNA TRIM2 CTRPv2 pan-cancer AAC 0.14 0.0007
mRNA CMTR1 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA BUB1 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA CCDC167 CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA UNCX CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA LMOD1 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA TLR9 CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA LPAR2 CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA NIPAL2 CTRPv2 pan-cancer AAC 0.12 0.0008
Download CSV